Antigen binding proteins that interact with ASGR, ASGR-1 and/or ASGR-2 aredescribed as well as methods of makingand using such antigen binding proteins. Methods of treating and preventingcardiovascular disease by administering a pharmaceuticallyeffective amount of ASGR, ASGR-1 and/or ASGR-2 antigen binding proteins.Methods of treating and preventing cardiovasculardisease by administering a pharmaceutically effective amount of interferingRNA compositions that reduce expression ofASGR, ASGR-1 and/or ASGR-2 are described.